Innovative synthetic biology techniques are revolutionizing microbiota-based therapies, enhancing microbial functions for ...

This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...

The field of cancer research is rapidly evolving, with a growing focus on the intersection of cancer immunology, gene editing, and epigenetics. This ...

Stock analysts at Cantor Fitzgerald issued their FY2025 earnings per share (EPS) estimates for shares of CRISPR Therapeutics ...

Despite all of today’s options for optimizing the bioprocessing of fungal secondary metabolites, researchers pointed out the ...

In a Phase I/II trial, patients with X-linked chronic granulomatous disease will receive a treatment created using a new ...

Arkadios Wealth Advisors lifted its position in shares of CRISPR Therapeutics AG (NASDAQ:CRSP – Free Report) by 7.7% during the 4th quarter, according to the company in its most recent Form 13F filing ...

This is a useful study that seeks to address the role of the TET family of DNA demethylation enzymes in pancreatic beta cell senescence in the context of type 2 diabetes (T2DM). Although the concepts ...

Simultaneous discoveries in art and science highlight humanity's shared creativity, problem-solving, and the ...

Cystic fibrosis (CF) is a life-threatening genetic disease affecting multiple organ systems, with pancreatic dysfunction representing a critical and often overlooked complication.

The National Institutes of Health has awarded an Oklahoma Medical Research Foundation scientist a $4.1 million grant to study ...

It feels fantastic,” said Blau, who thanked her lab members and colleagues for their support and dedication. “This ...